It’s generally known that Alzheimer’s disease is a neurological condition that primarily targets the brain. However, new information suggests that it actually starts somewhere else in the body. As such, scientists are suggesting to take even better care of one’s physical and mental health to reduce the chances of developing the degenerative condition.
The new data was presented by a joint effort of Canadian and Chinese researchers who posted their findings on the Molecular Psychiatry journal. According to their study, Alzheimer’s might actually start somewhere other than the brain. This is due to how the condition is caused by the build-up of beta-amyloid proteins and tau proteins.
“In this study, using a model of parabiosis between APPswe/PS1dE9 transgenic AD mice and their wild-type littermates, we observed that the human Aβ originated from transgenic AD model mice entered the circulation and accumulated in the brains of wild-type mice, and formed cerebral amyloid angiopathy and Aβ plaques after a 12-month period of parabiosis,” the paper reads.
The key takeaway here is the beta-amyloid build-up because this protein is actually produced by other parts of the body. At any given moment, the human body produces the protein, which then crosses the blood-brain barrier. As a result, the protein gets stuck in the brain, which results in Alzheimer’s.
These findings could result in a huge shift in how the degenerative disease might be approached in the future. Right now, Alzheimer’s treatments largely focus on the brain, Futurism reports. As this study suggests, however, scientists might want to look into other parts of the body. More specifically, perhaps more focus should be given to the build-up of beta-amyloid.
Doing so could finally alleviate the burden that the care of patients with Alzheimer’s or dementia is causing. In 2016 alone, the U.S. has spent $236 billion in caring for such patients.


Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
U.S. Greenlights Nvidia H200 Chip Exports to China With 25% Fee
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms
SK Hynix Labeled “Investment Warning Stock” After Extraordinary 200% Share Surge
Trump Signs Executive Order to Establish National AI Regulation Standard
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 



